NZ240695A - Stabilised aqueous antiseptic compositions containing 5-aminohexahydropyrimidine derivatives - Google Patents

Stabilised aqueous antiseptic compositions containing 5-aminohexahydropyrimidine derivatives

Info

Publication number
NZ240695A
NZ240695A NZ240695A NZ24069591A NZ240695A NZ 240695 A NZ240695 A NZ 240695A NZ 240695 A NZ240695 A NZ 240695A NZ 24069591 A NZ24069591 A NZ 24069591A NZ 240695 A NZ240695 A NZ 240695A
Authority
NZ
New Zealand
Prior art keywords
aminohexahydropyrimidine
derivatives
compositions containing
antiseptic compositions
aqueous antiseptic
Prior art date
Application number
NZ240695A
Inventor
Edward J Carlin
Anil K Talwar
Steven S Dills
Joseph M Talmage
Eugene C Samarco
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NZ240695A publication Critical patent/NZ240695A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
NZ240695A 1990-11-26 1991-11-22 Stabilised aqueous antiseptic compositions containing 5-aminohexahydropyrimidine derivatives NZ240695A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61772990A 1990-11-26 1990-11-26

Publications (1)

Publication Number Publication Date
NZ240695A true NZ240695A (en) 1993-10-26

Family

ID=24474821

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ240695A NZ240695A (en) 1990-11-26 1991-11-22 Stabilised aqueous antiseptic compositions containing 5-aminohexahydropyrimidine derivatives

Country Status (6)

Country Link
EP (1) EP0512104A1 (en)
CA (1) CA2074484A1 (en)
MX (1) MX9102200A (en)
NZ (1) NZ240695A (en)
WO (1) WO1992009283A1 (en)
ZA (1) ZA919297B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496558A (en) * 1993-03-02 1996-03-05 Block Drug Company Inc. Solid form xerostomia product
EP1029543B1 (en) * 1999-02-19 2002-11-20 Warner-Lambert Company Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
US7893223B2 (en) 2001-07-17 2011-02-22 Bracco Imaging S.P.A. Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
ITMI20011518A1 (en) * 2001-07-17 2003-01-17 Bracco Imaging Spa MULTIDENTATED NITROGEN BINDERS CAPABLE OF COMPLEXING METAL IONS AND THEIR USE IN DIAGNOSTICS AND THERAPY

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666517A (en) * 1986-06-04 1987-05-19 Colgate-Palmolive Co. Antiplaque oral composition
US4774078A (en) * 1986-10-06 1988-09-27 Colgate-Palmolive Company Stable antiplaque dentifrice based on hexetidine, zinc ion and fluoride
US4992276A (en) * 1988-12-14 1991-02-12 Warner-Lambert Company Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and thymol and methods for preparing same
EP0408174A1 (en) * 1989-07-12 1991-01-16 Warner-Lambert Company Antiseptic composition containing hexahydro-5-pyrimidinamine compounds
GB9008433D0 (en) * 1990-04-12 1990-06-13 Beecham Group Plc Novel compositions
FR2661091B1 (en) * 1990-04-18 1994-10-21 Andre Salkin USE OF HEXETIDINE OR ITS DERIVATIVES OR SALTS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR OPHTHALMOLOGICAL USE.

Also Published As

Publication number Publication date
CA2074484A1 (en) 1992-05-27
MX9102200A (en) 1992-07-08
ZA919297B (en) 1992-08-26
EP0512104A1 (en) 1992-11-11
WO1992009283A1 (en) 1992-06-11

Similar Documents

Publication Publication Date Title
AP9200402A0 (en) New aqueous formulations
GB2251791B (en) Pharmaceutical compositions containing benzenesulphonamides
EP0586537A4 (en) Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
GB9127178D0 (en) Suds-controlling composition for aqueous compositions
GB9207799D0 (en) Aqueous compositions
EP0580409A3 (en) Cosmetic composition containing dopa derivatives
GB9124733D0 (en) Derivatives of poly-4-amino-2-carboxy-1-methyl compounds
GB2251617B (en) Pharmaceutical compositions containing substituted 3-hydroxypyridin-4-ones
EP0512710A3 (en) Aqueous coating compositions
IL98749A0 (en) Pharmaceutical compositions containing penciclovir
IL103747A0 (en) Saccharin derivatives and pharmaceutical compositions containing them
EP0511792A3 (en) Pyridoprimidine derivatives as antineoplastic agents
IL101120A0 (en) Preparation of 13c-labelled compounds
NZ240695A (en) Stabilised aqueous antiseptic compositions containing 5-aminohexahydropyrimidine derivatives
IL99426A0 (en) Pharmaceutical compositions containing benzoyl urea derivatives
HK218996A (en) Pharmaceutical formulation containing penciclovir
IL102539A0 (en) Preparation of 17beta-substituted-4-aza 5alpha-androstan-3-one derivatives
ZA924116B (en) Cosmetic compositions containing chalone derivatives
GB9204224D0 (en) Aqueous compositions
GB9115054D0 (en) Aqueous compositions
GB9121205D0 (en) Derivatives of poly-5-amino-3-carboxy-1-methyl compounds
GB2242427B (en) Preparation of thieno-triazolo-diazepine derivatives
HU9400358D0 (en) Use of quinoziline derivatives as orexigenics
GB2243829B (en) Preparation of thieno-triazolo-diazepine derivatives
ZA937537B (en) Aqueous composition